Page 372 - FINAL PROGRAMME 2017

17:00 - 18:15: Industry sponsored symposium: Gedeon Richter
Transforming fertility management
Chairs
Bart C.J.M. Fauser, The Netherlands Marc Germond, Switzerland
Fibroids and fertility: From present to future
Jacques Donnez, Belgium
Safeguarding fertility: Why the debate?
Michaël Grynberg, France
Preventing transmission of abnormal mitochondrial DNA
Alison Murdoch, United Kingdom
Tuesday, 4 July
11:45 - 13:00: Industry sponsored symposium: Merck
11:45 - 11:50 11:50 - 11:55 11:55 - 12:15
12:15 - 12:35 12:35 - 12:55 12:55 - 13:00
Reducing time to live birth by optimizing ovarian response and embryo assessment Welcome
Thomas D’Hooghe, Belgium
Introduction: Impact of female age and treatment discontinuation on time to live birth
Christian De Geyter, Switzerland
Optimizing ovarian response with personalized rFSH starting dose selection and exible dose adaptation
Human Mousavi Fatemi, United Arab Emirates
Recombinant LH supplementation during ovarian stimulation: impact on oocyte quality and live birth
Carlo Alviggi, Italy
Improving reproductive outcomes with continuous embryo assessment
Geoffrey David Adamson, U.S.A.
Summary and closing remarks
Christian De Geyter, Switzerland
13:00 - 14:00: Industry sponsored session: Vitrolife
Securing improved work ow ef ciency in practice
Chair
David K. Gardner, Australia
Quality and work ow ef ciency - two sides of the same coin
Markus Montag, Germany
Using ef ciencies from time-lapse technology to reduce the cost of IVF
Cristina Hickman, United Kingdom
Time-ef cient vitri cation will support work ow optimisation
Hubert Joris, Sweden
372